Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our...
top of page
Search
Antheia
- Feb 16
Synthetic Biology vs Synthetic Chemistry: A Primer
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active...
Antheia
- Dec 8, 2022
Antheia's 2022 in Review: A Year of Value
Dear colleagues, friends, and followers: This year has been ripe with growth, major achievements, and opportunities to showcase who and...
Antheia
- Dec 7, 2022
In the News: Drug Discovery and Development 2023 Predictions
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take...
Antheia
- Nov 20, 2022
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency...
Antheia
- Oct 30, 2022
In the News: Contract Pharma, Leveraging Fermentation to Produce Complex APIs
In this Contract Pharma Q&A, we sat down with Kristin Brooks to discuss how our company uses fermentation to produce complex APIs for...
![Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]](https://static.wixstatic.com/media/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png/v1/fill/w_439,h_330,fp_0.50_0.50,q_95,enc_auto/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png)
Antheia
- Sep 28, 2022
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Antheia CEO and co-founder Christina Smolke shared how synthetic biology can help solve pressing pharma challenges during the 2022 CPHI...
Antheia
- Aug 25, 2022
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Dive into DSP in the final edition of our Demystifying SynBio series. If you’re just joining us, be sure to catch up on parts I, II, III,...
Antheia
- Aug 16, 2022
Introducing Guerin Kob, Antheia’s VP of Supply Chain
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply...
Antheia
- Jul 18, 2022
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Learn more about synbio and the tools and technologies advancing this field in Part I, Part II, and Part III of this blog series....
Antheia
- Jun 22, 2022
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Financing will support new plant at Antheia headquarters to accelerate scale up for company’s pipeline of plant-based compounds; plant...
Antheia
- Jun 12, 2022
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Just joining us? Check out Part I and Part II of the series. Synthetic biology is often touted as a software-driven and...
Antheia
- Jun 6, 2022
Introducing CPO Heidi Pucel
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people...
Antheia
- Apr 14, 2022
In the News: Antheia Senior Scientist Involved in Cancer Research Discovery
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support...
Antheia
- Apr 13, 2022
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Just joining us? Start with part one of our demystifying synthetic biology series. Synthetic biology seems like a brand-new, precision...
Antheia
- Feb 22, 2022
Antheia Appoints Heidi Pucel as Chief People Officer
MENLO PARK, Calif., Feb. 22, 2022 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation plant-inspired medicines,...
Antheia
- Feb 9, 2022
Demystifying Synthetic Biology: Building with the power of biology
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever...
Antheia
- Jan 5, 2022
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons...
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons She Learned From Her Experience As a...
Antheia
- Jan 5, 2022
Seven Biopharma Trends to Watch in 2022
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group...
Antheia
- Jan 4, 2022
In the News: Seven Biopharma Trends to Watch in 2022
Dr. Christina Smolke provides visionary insight on the trends shaping biopharma in 2022. Against a backdrop of skeptical news about the...
Antheia Newsroom
bottom of page